… 17, regulatory T cells, cytokines, and their balance in the prognosis and therapy of atherosclerosis.
… T cells present during all stages of the disease are essential to the development of …

… Although experimental evidence suggests that cytokine and chemokine targeting may hold
… anti-cytokine therapy. Dissection of protective and maladaptive cellular actions of cytokines in …

… inflammatory cytokine production and inflammasome activity through anti-inflammatory cytokine
… -triggered TNF secretion as well as other pro-atherogenic cytokines such as IL-12, IL-23, …

… role in various stages of plaque … to cytokine subtypes with several diseases associated
with endothelial dysfunction [83]. The balance between pro- and anti-inflammatory cytokines …

… the cytokine in the atherosclerosis lesions. IL10 delivered by NC was bioactive and reduced
the production of pro-inflammatory cytokine … cytokine delivery for preventing atherosclerotic …

… of phenotypes linked with differential cytokine development and functional parameters. This
… The initial stages are manifested in infants under the age of one year, and atherosclerotic …

… Systemic administration of doxycycline resulted in a reduction of atherosclerotic lesion
size and proatherogenic cytokine production in heterozygous apolipoprotein E-deficient mice …

… , which are present throughout all stages of the disease, many of which are immunoreactive
… immune cells in atherosclerotic plaques is influenced by chemokines and cytokines. We …

… cytokine and a potential biomarker of disease progression. … stimulation with different
combination of cytokines. One of the … Future studies in human AKI at different disease stages are …

… the release of cytokines. All of these functions have the potential to affect atherosclerosis by
… B cell subsets, locations within the body, and stages of the disease. We are still far from a …